Amgen ($AMGN) has provided further evidence that its $415 million bet on deCode Genetics’ trove of genomic data can pay off. The latest validation of the deal ...
HealthDay News — ASGR1 mutation carriers have reduced levels of non-high-density lipoprotein cholesterol (HDL-C) and reduced risk of coronary artery disease, according to a study published online May ...
Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and Copenhagen University, published a study today in the journal Cell titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback